Long-term psychological stress drives breast cancer progression through neuroendocrine, immune, and gut microbiota (GM) dysbiosis. Preclinical and clinical data link stress-induced depletion of Akkermansia muciniphila and its cross-fed metabolite, butyrate, to the activation of the Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5)-Wnt/β-catenin signaling pathway and increased cancer stemness. However, the current evidence has critical limitations. A. muciniphila does not produce butyrate, and its effects are highly context-dependent. While gut-resident populations are generally beneficial, translocation to mammary tissue can paradoxically induce oxidative stress and promote tumor progression. Therefore, future interventions must move beyond indiscriminate live bacterial supplementation. For the safe management of stress-associated breast cancer, future research should prioritize tissue-context-aware strategies, such as harnessing postbiotics (e.g., purified Amuc_1100, extracellular vesicles) and bacterial metabolites (e.g., targeted butyrate modulation), or utilizing high-fiber diets, integrated with established psycho-oncological care.
No takes yet. Share an insight, caveat, or question.
Rubio‐Casillas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: